DOG1: A novel marker of salivary acinar and intercalated duct differentiation

Modern Pathology

Volumn 25, Issue 7, 2012, Pages 919-929

  Chênevert, Jacinthe ^a   Duvvuri, Umamaheswar ^a   Chiosea, Simion ^a   Dacic, Sanja ^a   Cieply, Kathleen ^a   Kim, Jean ^a   Shiwarski, Daniel ^a   Seethala, Raja R ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

acinic cell carcinoma; DOG1; salivary gland

Indexed keywords

CHLORIDE CHANNEL; MESSENGER RNA; PROTEIN ANOCTAMIN 1; UNCLASSIFIED DRUG;

ACINAR CELL CARCINOMA; ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ANOCTAMIN 1 GENE; APICAL MEMBRANE; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CELL STRAIN; CONTROLLED STUDY; CYSTADENOCARCINOMA; CYTOPLASM; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MYOEPITHELIOMA; MYOEPITHELIUM CELL; ONCOCYTOMA; PHENOTYPIC VARIATION; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND DUCT; SALIVARY GLAND TUMOR; SEBACEOUS CARCINOMA; SQUAMOUS CELL; TUMOR GENE; WARTHIN TUMOR;

ACINAR CELLS; CARCINOMA; CARCINOMA, ACINAR CELL; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CHLORIDE CHANNELS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SALIVARY DUCTS; SALIVARY GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84863432600     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.57     Document Type: Article

References (29)

1. West RB, Corless CL, Chen X, et al. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol 2004;165:107-113. (Pubitemid 38821818)
2. Lee CH, Liang CW, Espinosa I. The utility of discovered on gastrointestinal stromal tumor 1 (DOG1) antibody in surgical pathology-the GIST of it. Adv Anat Pathol 2010;17:222-232.
3. Miettinen M, Wang ZF, Lasota J. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Am J Surg Pathol 2009;33: 1401-1408.
4. Carles A, Millon R, Cromer A, et al. Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display. Oncogene 2006;25:1821-1831.
5. Caputo A, Caci E, Ferrera L, et al. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science 2008;322:590-594.
6. Schroeder BC, Cheng T, Jan YN, et al. Expression cloning of TMEM16A as a calcium-activated chloride channel subunit. Cell 2008;134:1019-1029.
7. Yang YD, Cho H, Koo JY, et al. TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature 2008;455:1210-1215.
8. Ferrera L, Caputo A, Galietta LJ. TMEM16A protein: a new identity for Ca(2+)-dependent Cl channels. Physiology (Bethesda) 2010;25:357-363.
9. Hwang DG, Qian X, Hornick JL. DOG1 antibody is a highly sensitive and specific marker for gastrointestinal stromal tumors in cytology cell blocks. Am J Clin Pathol 2011;135:448-453.
10. Almaca J, Tian Y, Aldehni F, et al. TMEM16 proteins produce volume-regulated chloride currents that are reduced in mice lacking TMEM16A. J Biol Chem 2009;284:28571-28578.
11. Kunzelmann K, Kongsuphol P, Aldehni F, et al. Bestrophin and TMEM16-Ca(2+) activated Cl(-) channels with different functions. Cell Calcium 2009;46:233-241.
12. Ousingsawat J, Martins JR, Schreiber R, et al. Loss of TMEM16A causes a defect in epithelial Ca2+-dependent chloride transport. J Biol Chem 2009;284: 28698-28703.
13. Ferrera L, Caputo A, Ubby I, et al. Regulation of TMEM16A chloride channel properties by alternative splicing. J Biol Chem 2009;284:33360-33368.
14. Skalova A, Vanecek T, Sima R, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol 2011;34:599-608.
15. Chiosea SI, Griffith C, Assaad A, et al. The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma. Am J Surg Pathol 2012; 36:343-350.
16. Chiosea SI, Griffith C, Assaad A, et al. Clinicopathologic characterization of mammary analogue secretory carcinoma of salivary glands. Histopathology 2012; e-pub ahead of print.
17. Bergmann F, Andrulis M, Hartwig W, et al. Discovered on gastrointestinal stromal tumor 1 (DOG1) is expressed in pancreatic centroacinar cells and in solid-pseudopapillary neoplasms-novel evidence for a histogenetic relationship. Hum Pathol 2011;42: 817-823.
18. Ardeleanu C, Arsene D, Hinescu M, et al. Pancreatic expression of DOG1: a novel gastrointestinal stromal tumor (GIST) biomarker. Appl Immunohistochem Mol Morphol 2009;17:413-418.
19. Davis AJ, Forrest AS, Jepps TA, et al. Expression profile and protein translation of TMEM16A in murine smooth muscle. Am J Physiol Cell Physiol 2010; 299:C948-C959.
20. Gomez-Pinilla PJ, Gibbons SJ, Bardsley MR, et al. Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol 2009;296:G1370-G1381.
21. Huang X, Godfrey TE, Gooding WE, et al. Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma. Genes Chromosomes Cancer 2006;45:1058-1069. (Pubitemid 44435540)
22. Childers EL, Ellis GL, Auclair PL. An immunohistochemical analysis of anti-amylase antibody reactivity in acinic cell adenocarcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;81:691-694. (Pubitemid 126812986)
23. Ihrler S, Blasenbreu-Vogt S, Sendelhofert A, et al. Differential diagnosis of salivary acinic cell carcinoma and adenocarcinoma (NOS). A comparison of (immuno-) histochemical markers. Pathol Res Pract 2002;198:777-783. (Pubitemid 36221699)
24. Batsakis JG, Pinkston GR, Luna MA, et al. Adenocarcinomas of the oral cavity: a clinicopathologic study of terminal duct carcinomas. J Laryngol Otol 1983;97:825-835. (Pubitemid 13041939)
25. Araujo V, Sousa S, Jaeger M, et al. Characterization of the cellular component of polymorphous low-grade adenocarcinoma by immunohistochemistry and electron microscopy. Oral Oncol 1999;35:164-172. (Pubitemid 29113059)
26. Griffith C, Seethala R, Chiosea SI. Mammary analogue secretory carcinoma: a new twist to the diagnostic dilemma of zymogen granule poor acinic cell carcinoma. Virchows Arch 2011;459:117-118.
27. Lopes LF, West RB, Bacchi LM, et al. DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): comparison between 2 different antibodies. Appl Immunohistochem Mol Morphol 2010;18:333-337.
28. Chetty R. Intercalated duct hyperplasia: possible relationship to epithelial-myoepithelial carcinoma and hybrid tumours of salivary gland. Histopathology 2000;37:260-263.
29. Weinreb I, Seethala RR, Hunt JL, et al. Intercalated duct lesions of salivary gland: a morphologic spectrum from hyperplasia to adenoma. Am J Surg Pathol 2009; 33:1322-1329.